A proposal to scale up production, complete preclinical studies, and launch first in human clinical trials for a world-first, dual-use universal blood and organ platform.
Avivo Biomedical Inc.
6 enregistrements totalisant 23,139,819.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Innovation, Sciences et Développement économique Canada | $21,988,000 | 2 enregistrements |
| Conseil national de recherches Canada | $982,819 | 3 enregistrements |
| Défense nationale | $169,000 | 1 enregistrement |
Enregistrements
A proposal to scale up production, complete preclinical studies, and launch first in human clinical trials for a world-first, dual-use universal blood and organ platform.
This project aims to further improve the A enzyme production platform for a final product for use all preclinical and subsequent clinical studies, as well as the integration of a new EnzBO1, a B antig...
This project focuses on further characterizing EnzBO2 by establishing an in-house enzyme kinetic characterization platform, scaling up regulatory quality production of A and B enzymes, and developing...
This project will involve the development of assay systems to test for and assess enzyme quality, purity and stability, as well as support for the development of monoclonal antibodies (for detection o...
Funding under the Innovator Stream will support continued research and development of solutions under National Defence’s Funding for Canadian Innovators and Accelerators of DIANA (FCIA-DIANA) program.